patients have reliable options for affordable medicines,” AAM President and CEO John Murphy III said in a statement.
“Our industry has several legislative and regulatory solutions to address the market deficiencies and we look forward to dialogue with the Administration and with Congress to pursue solutions that restore the generics industry to growth continue reading …
